阿尔茨海默病的研究随着新的血液检测、FDA 批准的治疗和护理人员支持计划而取得进展。 Alzheimer's research progresses with new blood tests, FDA-approved treatment, and support programs for caregivers.

2024年,阿尔茨海默氏症的研究取得了长足进步,为诊断目的进行了更准确的血液测试,林业发展局批准了Kisunla,这是减缓该疾病发展速度的治疗方法。 In 2024, Alzheimer's research made strides with more accurate blood tests for diagnosis and the FDA approval of Kisunla, a treatment to slow the disease's progression. 研究把野火烟与其他空气污染物相比,与痴呆症风险增加有关联,而阿尔茨海默氏病诊断的新标准现在包括身体大脑的变化。 Studies linked wildfire smoke to increased dementia risk more than other air pollutants, and new criteria for Alzheimer's diagnosis now include physical brain changes. 老年痴呆阿尔茨海默氏症协会与CMS共同发起了一个为期8年的方案,支持照顾者和病人。 Recognizing caregiver struggles, the Alzheimer's Association launched an 8-year program with CMS to support caregivers and patients.